advisorsecurities master

PBYIPUMA BIOTECHNOLOGY INC

CSNasdaq (XNAS)·USD

Identity

Security key
19930
Ticker
PBYI
Type
CSCommon Stock
Exchange
Nasdaq(XNAS)
Venue group
NASDAQ
Operating MIC
XNAS
Market
stocks
Locale
us
Currency
USD
Listed
2012-03-21
Round lot
100
Active
Yes
Last seen in a load
2026-08-14 20:49
Vendor updated
2026-08-13 06:09
Ticker root / suffix
PBYI

Detail

Enriched 2026-08-14 20:47

Market cap
$459,418,587.4
Shares outstanding (class)
51,620,066
Shares outstanding (weighted)
51,620,066
SIC
2834 PHARMACEUTICAL PREPARATIONS
Employees
179
Location
LOS ANGELES, CA
Description

Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes inventive products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also, it is developing Alisertib, a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis, resulting in apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.

Market cap and share counts drift.

Funds holding this security

Identifiers

Classification

Fund data